Last reviewed · How we verify

NCT03198299

Therapeutic Effects of Arch Support Insoles on Children

Completed NA Last updated 26 June 2017
What this trial tests

NA trial testing MEI BIN insoles in Normal Development in 45 participants. Completed in 31 December 2016.

Timeline
1 January 2016
Primary endpoint
31 December 2016
31 December 2016

Quick facts

Lead sponsorTaipei Medical University
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingdouble
Primary purposesupportive care
Enrollment45
Start date1 January 2016
Primary completion31 December 2016
Estimated completion31 December 2016
Sites1 location across Taiwan

Drugs / interventions tested

Conditions studied

Sponsor

Taipei Medical University

Who can join

Adults 3 to 10, any sex, with Normal Development. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Using double blind, randomized controlled design to study the short-term therapeutic effects of customized arch support insoles on children

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

  1. Customized Arch Support Insoles Improve Physical Functional Performance in Children: A Randomized Controlled Study
    Kuo Y, Hsieh R, Lee W. · · 2021 · DOI 10.21203/rs.3.rs-964161/v1

Verify or expand the search:

Other trials of MEI BIN insoles

Trials testing the same drug.

Other Taipei Medical University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03198299.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing